Abu Dhabi's Mubadala sets up new life sciences company

Dubai: Mubadala Investment Company PJSC has launched a new life sciences subsidiary, Mubadala Bio, to strengthen domestic drug manufacturing and position Abu Dhabi as a regional hub for biopharma innovation.

Mubadala Bio will focus on the production and distribution of therapeutic products, with an emphasis on enhancing national drug security and supporting the UAE’s economic diversification agenda. The company’s integrated portfolio comprises 10 manufacturing and distribution facilities across Asia, Africa, and Europe, including six located within the UAE.

The combined facilities span 110,000 square metres, with an annual production capacity exceeding 2.5 billion tablets and capsules, 120 million intravenous and injectable units, and distribution to over 100 countries. Mubadala Bio’s product portfolio includes more than 10,000 medical products, covering a broad range of therapy areas and the full continuum of care—from prevention and diagnosis to treatment and supportive care.

The company also aims to establish strategic partnerships with global life sciences firms and academic institutions, focusing on local biopharma innovation, talent development, and pharma logistics infrastructure. Mubadala Bio’s launch aligns with the UAE Centennial 2071 vision and will be formally introduced at Make it in the Emirates 2025, the country’s national industrial showcase.

Dr. Bakheet Al Katheeri, CEO of Mubadala’s UAE Investments Platform, said the launch marks “a transformative step” in reinforcing healthcare resilience and long-term economic growth.

Mubadala Bio is one of Mubadala’s designated “National Champions,” entities created to support strategic sectors aligned with the UAE’s long-term development goals. The company’s initiatives are aimed at accelerating the UAE’s transition to a knowledge-based economy, particularly in healthcare and biotechnology.

Mubadala manages a global portfolio valued at $330 billion (Dh1.21 trillion) across six continents and multiple sectors.